| European Animal Health Markets and Opportunities Published May 2007 |
 This report examines the size, structure and development of the EU market, and profiles the European operations of leading animal health product manufacturers.> About the report > Executive summary > Order |
Campaigns to eradicate conditions such as infectious animal diseases have generated substantial demand for veterinary vaccines in Europe. Approaches towards the control of serious disease outbreaks in the EU have shifted significantly, partly as a result of the 2001 FMD epidemic in the UK. Preventative and emergency vaccination strategies are now being accepted as valuable parts of broader approaches towards controlling and eradicating serious disease outbreaks.
Outbreaks of serious 'exotic' diseases such as avian influenza or foot and mouth disease have the potential to cause serious disruption to demand for animal health products, as recent events in parts of the region illustrate.
Many other diseases present market opportunities, however, and campaigns to eradicate conditions such as infectious bovine rhinotracheitis (cattle) and Aujeszky's disease (pigs) have generated substantial demand for veterinary vaccines in Europe. The relatively recent emergence of porcine reproductive and respiratory syndrome (PRRS) has also created a new - and sizeable - market for pig vaccines.
Approaches towards the control of serious disease outbreaks in the EU have shifted significantly since the beginning of this decade, partly as a result of the 2001 FMD epidemic in the UK, where around seven million animals were destroyed as the government there stuck rigidly to a slaughter-only policy. Preventative and emergency vaccination strategies are now being accepted more broadly as valuable parts of broader approaches towards controlling and eradicating serious disease outbreaks, and vaccines will be used more readily in future.
Immunological approaches are also being embraced more widely as part of food safety initiatives, and this, too, is set to generate rising demand for vaccines in the region. New EU regulations on salmonella in poultry are a case in point.
| Register for free FMD daily updates Get a four-week trial subscription |
 Receive FREE daily updates on foot and mouth disease+44 (0)20 7017 5540 > Register > Email us for details |
From January 2008, member states where the prevalence of salmonella in laying flocks is in excess of 10% must introduce vaccination programs against the infection. This will generate a substantial increase in sales of salmonella vaccines across the region during the forecast period.
Climatic trends will also have an impact on demand for some animal health products - notably antiparasitics. Mild, wet conditions in spring or summer encourage the development of high worm and fluke populations on livestock pasture, for example, while warm conditions are also conducive to the build-up of ectoparasite populations.
While it is impossible to predict how climate might effect demand in individual seasons, the general trend towards milder winters and warmer summers across large parts of Europe is encouraging the geographical spread of some parasites that were previously confined to southern areas of the region. Accordingly, demand for preventative or therapeutic treatments - and in some cases for vaccinations - will increase gradually.
Email a friend
Digital RSS Feed
